Newsroom > Articles


Medexprim is pleased to announce the appointment of Montaine Marteau as Chief Product and Technical Officer (CPTO), concurrently with her integration into the company’s Executive Committee, alongside Romain Cazavan, Nicolas Dubost and Fabrice Pillon.

In her role as CPTO, Montaine will steer Medexprim’s comprehensive Research and Development strategy, including the company’s product and technical strategy, as well as managing the development and engineering teams. In the rapidly structuring Real-World Data sector, her technical skills, strategic vision and leadership will prove pivotal in guiding Medexprim towards innovative choices in technological and product development.

Romain Cazavan, CEO, comments this nomination: “Montaine possesses innate human skills that make her an exceptional manager, coupled with a proven expertise in project management. For Medexprim, a company where 63% of the employees are women, her appointment as CPTO and inclusion in the Executive Committee are a natural fit. Her decade-long tenure at Varian is a valuable asset in executing our roadmap to converge clinical research with routine healthcare”.

For Montaine Marteau: “The opportunity to wear two hats, product and technical, is a great challenge which I accepted with enthusiasm. Within our Research and Development department, we are ready to innovate to meet the many exciting challenges of precision medicine.”

A biomedical engineer by training, specializing in image processing and trained in agile development, Montaine joined Medexprim in June 2022 as Senior Product Manager. Today, she oversees a team of six developers, three research engineers, and three product owners.

French version of the press release

About Medexprim
European leader in imaging & clinical data extraction, Medexprim bridges leading hospitals and pharmaceutical companies. Real-World data specialist, we help hospitals drive their research strategy and valorize their data. We provide our partners with secure access to multimodal, multicentric datasets for clinical research projects in oncology, cardiology, neurology, and rare diseases. We aim to structure the Real-World clinical and imaging data ecosystem in Europe to accelerate precision medicine.

Press contact: Anne-Sophie Labeta 

RSNA 2023: Medexprim brings European multi-imaging datasets to Innovation.

Medexprim, a leading European innovator in the field of Real-World Data and healthcare solutions,…

IQVIA clôture l’édition 2023 de son Accelerator Program, en collaboration…

IQVIA, spécialiste mondial d’analyses avancées, de solutions technologiques et de services de recherche clinique…

RSNA 2023: Medexprim brings European multi-imaging datasets to Innovation

Medexprim is set to showcase its cutting-edge, regulatory-grade multi-imaging and multimodal datasets at RSNA…

ESMO Congress 2023, D-1 / Medexprim spearheads Real-World Data to…

Medexprim, a leading innovator in the field of Real-World Data and healthcare solutions, is…